Injective Labs is a research and development company co-founded by Eric Chen and Albert Chon in 2018. Injective Labs focuses on creating Web3 infrastructure and finance technologies. It is one of the core contributors to Injective. From Wikipedia
The NYSE American-listed fintech targets roughly 12% annual returns through staking.